La bourse est fermée

QuidelOrtho Corporation (QDEL)

NasdaqGS - NasdaqGS Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
84,09-3,11 (-3,57 %)
À la clôture : 04:00PM EDT
84,25 +0,16 (+0,19 %)
Échanges après Bourse : 07:40PM EDT

QuidelOrtho Corporation

9975 Summers Ridge Road
San Diego, CA 92121
United States
858 552 1100

Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein6 900

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Douglas C. BryantChairman & CEO1,41MS.O.1958
Mr. Robert J. Bujarski J.D.Pres & COO770,62kS.O.1969
Ms. Michelle A. HodgesGen. Counsel620,61kS.O.1960
Dr. Werner Kroll Ph.D.Sr. VP of R&D758,22k2,1M1957
Mr. Joseph M. Busky CPAChief Financial OfficerS.O.S.O.1968
Ruben ArguetaDirector of Investor RelationsS.O.S.O.S.O.
Mr. Michael S. IskraChief Commercial OfficerS.O.S.O.1970
Phillip S. AskimVP, Associate Gen. Counsel & Sec.S.O.S.O.S.O.
Dr. Johannes KehlePres of AnDiaTec DivisionS.O.S.O.S.O.
Mr. Rhys de CallierVP of Strategy & Portfolio ManagementS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.


QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Gouvernance d’entreprise

L’ISS Governance QualityScore de QuidelOrtho Corporation en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.